A study in EBioMedicine reveals significant microplastic concentrations in thrombi from major blood vessels, linking microplastic levels to increased risk and severity of thrombotic events.
Atsena’s ATSN-201 receives FDA fast track status for XLRS
XLRS is marked by schisis, which causes impaired visual acuity. Credit: megaflopp/Shutterstock. Atsena Therapeutics has received fast track designation from the US Food and Drug